EdgarLookup

Core & Main, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Core & Main, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
5.8%
Profit Margin
Net income ÷ revenue
7.2%
Return on Assets
Net income ÷ assets
2.01x
Debt-to-Equity
Total liabilities ÷ equity
+2.8%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $7.65B Mar 24, 2026
FY2023 Feb 2, 2025 $7.44B Mar 24, 2026
FY2023 Jan 28, 2024 $6.70B Mar 24, 2026
FY2023 Jan 29, 2023 $6.65B Mar 25, 2025
FY2023 Jan 30, 2022 $5.00B Mar 19, 2024
FY2022 Jan 31, 2021 $3.64B Mar 28, 2023
FY2021 Feb 2, 2020 $3.39B Mar 30, 2022

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $2.06B Mar 24, 2026
FY2023 Feb 2, 2025 $1.98B Mar 24, 2026
FY2023 Jan 28, 2024 $1.82B Mar 24, 2026
FY2023 Jan 29, 2023 $1.80B Mar 25, 2025
FY2023 Jan 30, 2022 $1.28B Mar 19, 2024
FY2022 Jan 31, 2021 $878.00M Mar 28, 2023
FY2021 Feb 2, 2020 $789.00M Mar 30, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $441.00M Mar 24, 2026
FY2023 Feb 2, 2025 $411.00M Mar 24, 2026
FY2023 Jan 28, 2024 $371.00M Mar 24, 2026
FY2023 Jan 29, 2023 $366.00M Mar 25, 2025
FY2023 Jan 30, 2022 $92.00M Mar 19, 2024
FY2023 Jul 22, 2021 $74.00M Mar 19, 2024
FY2022 Jan 31, 2021 $37.00M Mar 28, 2023
FY2021 Feb 2, 2020 $36.00M Mar 30, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $722.00M Mar 24, 2026
FY2023 Feb 2, 2025 $719.00M Mar 24, 2026
FY2023 Jan 28, 2024 $740.00M Mar 24, 2026
FY2023 Jan 29, 2023 $775.00M Mar 25, 2025
FY2023 Jan 30, 2022 $425.00M Mar 19, 2024
FY2022 Jan 31, 2021 $185.00M Mar 28, 2023
FY2021 Feb 2, 2020 $155.00M Mar 30, 2022

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $1.15B Mar 24, 2026
FY2023 Feb 2, 2025 $1.08B Mar 24, 2026
FY2023 Jan 28, 2024 $931.00M Mar 24, 2026
FY2023 Jan 29, 2023 $880.00M Mar 25, 2025
FY2023 Jan 30, 2022 $717.00M Mar 19, 2024
FY2022 Jan 31, 2021 $556.00M Mar 28, 2023
FY2021 Feb 2, 2020 $509.00M Mar 30, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $650.00M Mar 24, 2026
FY2023 Feb 2, 2025 $621.00M Mar 24, 2026
FY2023 Jan 28, 2024 $1.07B Mar 24, 2026
FY2023 Jan 29, 2023 $401.00M Mar 25, 2025
FY2023 Jan 30, 2022 ($31.00M) Mar 19, 2024
FY2022 Jan 31, 2021 $214.00M Mar 28, 2023
FY2021 Feb 2, 2020 $194.00M Mar 30, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $6.09B Mar 24, 2026
FY2023 Feb 2, 2025 $5.87B Mar 24, 2026
FY2023 Jan 28, 2024 $5.07B Mar 25, 2025
FY2023 Jan 29, 2023 $4.91B Mar 19, 2024
FY2022 Jan 30, 2022 $4.43B Mar 28, 2023
FY2021 Jan 31, 2021 $3.92B Mar 30, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $4.01B Mar 24, 2026
FY2023 Feb 2, 2025 $4.10B Mar 24, 2026
FY2023 Jan 28, 2024 $3.55B Mar 25, 2025
FY2023 Jan 29, 2023 $2.50B Mar 19, 2024
FY2022 Jan 30, 2022 $2.60B Mar 28, 2023
FY2021 Jan 31, 2021 $3.12B Mar 30, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $2.00B Mar 24, 2026
FY2023 Feb 2, 2025 $1.70B Mar 24, 2026
FY2023 Jan 28, 2024 $1.45B Mar 25, 2025
FY2023 Jan 29, 2023 $1.75B Mar 19, 2024
FY2022 Jan 30, 2022 $1.33B Mar 28, 2023

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $1.92B Mar 24, 2026
FY2023 Feb 2, 2025 $1.90B Mar 24, 2026
FY2023 Jan 28, 2024 $1.56B Mar 24, 2026
FY2023 Jan 29, 2023 $1.54B Mar 25, 2025
FY2023 Jan 30, 2022 $1.52B Mar 19, 2024
FY2022 Jan 31, 2021 $1.45B Mar 28, 2023
FY2021 Feb 2, 2020 $1.36B Mar 30, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $755.00M Mar 24, 2026
FY2023 Feb 2, 2025 $449.00M Mar 24, 2026
FY2023 Jan 28, 2024 $189.00M Mar 25, 2025
FY2023 Jan 29, 2023 $458.00M Mar 19, 2024
FY2022 Jan 30, 2022 $92.00M Mar 28, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 $220.00M Mar 24, 2026
FY2023 Feb 2, 2025 $8.00M Mar 24, 2026
FY2023 Jan 28, 2024 $1.00M Mar 25, 2025
FY2023 Jan 29, 2023 $177.00M Mar 19, 2024
FY2022 Jan 30, 2022 $1.00M Mar 28, 2023
FY2021 Jan 31, 2021 $381.00M Mar 30, 2022

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 2 Mar 24, 2026
FY2023 Feb 2, 2025 2 Mar 24, 2026
FY2023 Jan 28, 2024 2 Mar 24, 2026
FY2023 Jan 29, 2023 2 Mar 19, 2024
FY2023 Jan 30, 2022 2 Mar 25, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2023 Feb 1, 2026 2 Mar 24, 2026
FY2023 Feb 2, 2025 2 Mar 24, 2026
FY2023 Jan 28, 2024 2 Mar 24, 2026
FY2023 Jan 29, 2023 2 Mar 19, 2024
FY2023 Jan 30, 2022 2 Mar 25, 2025